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OBJECTIVE—In diabetes, -cell mass is not static but in a
constant process of cell death and renewal. Inactivating muta-
tions in transcription factor 1 (tcf-1)/hepatocyte nuclear factor1a
(hnf1a) result in decreased -cell mass and HNF1A–maturity
onset diabetes of the young (HNF1A-MODY). Here, we investi-
gated the effect of a dominant-negative HNF1A mutant (DN-
HNF1A) induced apoptosis on the regenerative capacity of INS-1
cells.
RESEARCH DESIGN AND METHODS—DN-HNF1A was ex-
pressed in INS-1 cells using a reverse tetracycline-dependent
transactivator system. Gene(s)/protein(s) involved in -cell re-
generation were investigated by real-time quantitative RT-PCR,
Western blotting, and immunohistochemistry. Pancreatic stone
protein/regenerating protein (PSP/reg) serum levels in human
subjects were detected by enzyme-linked immunosorbent assay.
RESULTS—We detected a prominent induction of PSP/reg at
the gene and protein level during DN-HNF1A–induced apoptosis.
Elevated PSP/reg levels were also detected in islets of transgenic
HNF1A-MODY mice and in the serum of HNF1A-MODY patients.
The induction of PSP/reg was glucose dependent and mediated
by caspase activation during apoptosis. Interestingly, the super-
natant from DN-HNF1A–expressing cells, but not DN-HNF1A–
expressing cells treated with zVAD.fmk, was sufﬁcient to induce
PSP/reg gene expression and increase cell proliferation in naïve,
untreated INS-1 cells. Further experiments demonstrated that
annexin-V–positive microparticles originating from apoptosing
INS-1 cells mediated the induction of PSP/reg. Treatment with
recombinant PSP/reg reversed the phenotype of DN-HNF1A–
induced cells by stimulating cell proliferation and increasing
insulin gene expression.
CONCLUSIONS—Our results suggest that apoptosing INS-1
cells shed microparticles that may stimulate PSP/reg induction in
neighboring cells, a mechanism that may facilitate the recovery
of -cell mass in HNF1A-MODY. Diabetes 59:2799–2808, 2010
M
aturity-onset diabetes of the young (MODY) is
a familial form of non–insulin-dependent dia-
betes characterized by early onset of disease,
autosomal dominant inheritance, and insulin
secretory defects (1). MODY type 3 results from mutations
in the gene encoding transcription factor-1/hepatocyte
nuclear factor1a (tcf-1/hnf1a) (2), recently denoted as
HNF1A-MODY. HNF1A belongs to a network of transcrip-
tion factors controlling organ-speciﬁc gene expression
during embryonic development and in adult tissues (3).
Previous studies demonstrated that HNF1A is expressed in
adult -cells and regulates genes involved in glucose and
lipid homeostasis as well as -cell–speciﬁc genes (4–10).
Transgenic mice carrying a deletion of the hnf1a gene
have defective glucose-stimulated insulin secretion with-
out insulin resistance in target tissues (3), similar to
individuals with HNF1A-MODY (11). Findings from animal
and cellular models of HNF1A-MODY suggest a decline in
functional -cell mass as the primary mechanism of this
defect (8,12,13). Previous studies from our and other
laboratories have shown that gene knockout of HNF1A or
expression of dominant-negative mutants of HNF1 (DN-
HNF1) inhibits AKT signaling, decreases cell prolifera-
tion, and renders cells susceptible to apoptosis (8,14,15).
Evidence is growing that -cell mass is not static but in a
constant process of cell death and renewal (16). However,
it remains unclear in these models how increased -cell
apoptosis is linked to a compensatory stimulation of
regenerative processes.
The Regenerating (Reg) gene family belongs to the
calcium-dependent lectin gene superfamily (17). Pancre-
atic stone protein (PSP) was identiﬁed from extracts of
calciﬁed pancreatic concrements (18). Regenerating pro-
tein (reg) was independently identiﬁed in a screen of a
regenerating islet-derived cDNA library taken from 90%
depancreatized rats (19) and was found to be identical to
PSP (20). Subsequent studies highlighted the potential role
for the Reg gene family in pancreatic regeneration (21). We
investigated the expression of the PSP/reg gene during
DN-HNF1A–induced apoptosis and found PSP/reg to be
prominently upregulated. We also provide biochemical
evidence that apoptotic cells shed microparticles that may
stimulate PSP/reg induction in neighboring cells, thereby
linking -cell apoptosis with -cell regeneration.
RESEARCH DESIGN AND METHODS
INS-1 cells overexpressing HNF1A in an inducible system. Rat insuli-
noma INS-1 cells overexpressing wild-type HNF1A (WT-HNF1A) or DN-
HNF1A under control of a doxycycline-dependent transcriptional activator
have been described previously (4,8). Cells were cultured in RPMI-1640 at 6
mmol/l glucose supplemented with 10% FBS (PAA, Co ¨lbe, Germany), 2 mmol/l
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cin, 10 mmol/l HEPES (pH 7.4), and 50 mol/l 2-mercaptoethanol (Sigma,
Dublin, Ireland). For experiments investigating glucose dependence of PSP/
reg induction, expression of DN-HNF1A was induced for 24 h and continued
for a further2hi nmedium supplemented with glucose at 3, 6, 12, and 18
mmol/l. For caspase inhibition, cells were preincubated with 100 mol/l of the
broad-spectrum caspase inhibitor zVAD.fmk (Bachem, St. Helen’s, U.K.) for 45
min prior to induction.
Real-time quantitative RT-PCR. cDNA synthesis was performed using 1.5
g total RNA as the template and Superscript II reverse transcriptase
(Invitrogen, Paisley, U.K.) primed with 50 pmol random hexamers (New
England Biolabs, Ipswich, MA). Real-time PCR was performed using the
LightCycler 2.0 (Roche Diagnostics, Indianapolis, IN) and the QuantiTech
SYBR Green PCR kit (Qiagen). Speciﬁc PCR primers were designed using
Primer3 software (sequences available on request). For absolute quantiﬁca-
tion of hnf1a copy number, a gene-speciﬁc PCR amplicon of known concen-
tration was prepared as a standard. Melting curve analysis and gel
electrophoresis was utilized to verify speciﬁcity of all PCR products. The data
were analyzed using LightCycler software, version 4.0, with all samples
normalized to -actin.
Western blotting. For Western blotting analysis, 25 g protein lysates were
obtained from INS-1 cells overexpressing WT-HNF1A and DN-HNF1A as
described (9). The rabbit polyclonal anti-PSP/reg antibody (22) was diluted
1:20,000 in Tris-buffered saline containing 1% bovine serum albumin. The
primary mouse monoclonal anti–-actin antibody was utilized at a 1:10,000
dilution (Sigma). Horseradish peroxidase–conjugated secondary antibodies
were obtained from Pierce and detected using SuperSignal West Pico Chemi-
luminescent Substrate (Pierce) and imaged using a FujiFilm LAS-3000 imaging
system (Fuji, Shefﬁeld, U.K.).
Immunohistochemistry. Parafﬁn-embedded pancreatic sections from rat
insulin promoter (RIP)-DN-HNF1A and control wild-type C57BL/6JBomTac
mice (13) were deparafﬁnized and incubated overnight at 4°C with the rabbit
polyclonal anti-PSP/reg antibody diluted 1:20 (22). Speciﬁcity of the antibody
was conﬁrmed by Western blotting experiments using recombinant human
PSP/reg protein as a control. Slides were incubated for1ha troom temper-
ature in rhodamine-labeled anti-rabbit secondary antibody (1:100; Jackson
Immunoresearch, Suffolk, U.K.). Slides were incubated again overnight at 4°C
with the second primary guinea pig anti-insulin antibody (1:20; DakoCytoma-
tion A0564) followed by1ha troom temperature in ﬂuorescein isothiocyanate
(FITC)-labeled anti-goat secondary antibody (1:100; Jackson Immunore-
search) and mounted in Vectashield with DAPI (Vector Shield; Vector Labs,
Burlingame, CA). Images were taken with a Zeiss LSM710 confocal micro-
scope equipped with a 40  1.3NA oil-immersion objective (Carl Zeiss, Jena,
Germany). FITC was excited at 488 nm with an argon laser, using a
488/543-nm multichroic beam splitter, and the emission was collected at a 490-
to 550-nm spectral band. Rhodamine was excited at 543 nm with a helium
neon laser, using the same beam splitter, and the emission was collected at a
570- to 650-nm spectral band. DAPI was excited using the 405 nm DPSS laser
and a 405-nm dichroic beam splitter. DAPI ﬂuorescence was detected in the
420- to 480-nm spectral band. Images were processed using Zeiss LSM 4.2
software (Carl Zeiss). Rhodamine-positive cells in the periphery and interior
of the islet were quantiﬁed as a percentage of total islet cells using Image J
software.
Determination of caspase-3–like protease activity. INS-1 cells were
seeded at 1  10
5 per ml on a 24-well plate and allowed to settle overnight.
Following treatment cells were lysed in 200 l lysis buffer (10 mmol/l HEPES,
pH 7.4; 42 mmol/l KCl; 5 mmol/l MgCl2; 1 mmol/l phenylmethylsulfonyl
ﬂuoride; 0.1 mmol/l EDTA; 0.1 mmol/l EGTA; 1 mmol/l dithiothreitol [DTT]; 1
g/ml pepstatin A; 1 g/ml leupeptin; 5 g/ml aprotinin; and 0.5% 3-[{3-
cholamidopropyl}dimethylammonio]-1-propane sulfonate [CHAPS]). Fifty mi-
croliters of this lysate was then added to 150 l reaction buffer (25 mmol/l
HEPES, 1 mmol/l EDTA, 0.1% CHAPS, 10% sucrose, and 3 mmol/l DTT, pH 7.5)
containing 10 mol/l Ac-DEVD-AMC, which is efﬁciently cleaved by the
apoptotic executioner caspases 3 and 7, among others (23). Cleavage of the
substrate DEVD-AMC resulting in the accumulation of ﬂuorescent AMC was
measured on a Genios ﬂuorescence plate reader (Tecan) using 355 nm
excitation and 460 nm emission wavelengths as previously described (9).
Protein content was determined using the Pierce Coomassie Plus Protein
assay reagent (Perbio) and activity expressed as change in ﬂuorescent units
per microgram of protein per hour.
Detection of nuclear apoptosis. Cells were stained using DAPI to visualize
nuclear morphology. Condensed and/or fragmented nuclei were considered
apoptotic and observed using an Eclipse TE 300 inverted microscope (Nikon,
Dusseldorf, Germany) and a 20  dry objective, with DAPI excited at 340 
25 nm and the emission collected between 450 and 500 nm.
5-Bromo-2-deoxyuridine cell proliferation assay. Cellular proliferation
was assessed by means of bromodeoxyuridine (5-bromo-2-deoxyuridine
[BrdU]) incorporation using the BrdU Cell Proliferation Assay (Calbiochem).
BrdU was added to cells for 24 h, and cells were ﬁxed following treatment.
Following incubations with the primary and secondary antibodies, the perox-
idase-labeled secondary antibody was detected by addition of substrate
solution for 15 min and the reaction stopped. Absorbance was read using a
Bio-Rad 550 microplate reader at dual wavelengths of 450/540 nm. The values
for the background wells were subtracted from all values. The data were
normalized to noninduced control.
Microparticle isolation and puriﬁcation. Cell supernatants were centri-
fuged (500g; 15 min) to remove ﬂoating cells and medium containing micro-
particles released from INS-1 cells collected following an established protocol
(24). The medium was ﬁltered using 0.2-m ﬁlters (VWR International, Dublin,
Ireland) in order to remove microparticles. Microparticles were analyzed on a
Coulter EPICS XL ﬂow cytometer (Beckman Coulter, Villepinte, France) as
previously described (25). Regions corresponding to microparticles were
identiﬁed in forward light scatter and side-angle light scatter dot plots using a
logarithmic gain. The gate for microparticles was deﬁned as events with a 0.1-
to 1-m diameter, in comparison with calibrator beads (Megamix ﬂuorescent
beads of 0.5, 0.9, and 3 m in diameter; Biocytex, Marseille, France), and
plotted on an FL/FSC dot plot to determine the microparticles. Microparticles
were deﬁned as membrane vesicles 1 mol/l in diameter and expressing
externalized phosphatidylserine. Phosphatidylserine was labeled using FITC-
conjugated annexin V (Roche Diagnostics, Meylan, France) in the presence or
absence (negative control) of CaCl2 (5 mmol/l) as reported earlier (25).
Preparation of recombinant human PSP/reg protein. The recombinant
human PSP/reg protein was generated as previously described (22,26). Brieﬂy,
the coding region of PSP/reg was cloned into a transfer vector (pPIC9;
Invitrogen) containing the signal sequence of the yeast -mating factor to
drive the protein into the secretory pathway.
Subjects and clinical and laboratory measurements. Sixteen diabetic
subjects with mutations in the HNF1A gene (P291fsinsC, n  9 and p.Ser353fs,
n  7) were identiﬁed from an Irish MODY collection. Sequencing of the
HNF1A gene was performed by IntegraGen (Bonn, Germany). Control sub-
jects were ﬁrst-degree relatives of HNF1A-positive subjects who were nondi-
abetic and negative for the known HNF1A mutation in their pedigree (n  7).
In addition, 10 GAD- and/or islet antibody–positive patients with type 1
diabetes were recruited in the Mater Misericordiae University Hospital.
Anthropometric measurements including weight, height, and BMI were ob-
tained. The plasma glucose concentration was measured using an YSI analyser
(Roche). A1C was determined using high-performance liquid chromatography
(Menarini HA81-10, Rome, Italy). Anti-GAD was analyzed using competitive
ﬂuid-phase radioimmunoassay by the neuroscience group at John Radcliffe
Hospital, Oxford, U.K., and islet cell antibodies by University College London
Medical School by similar means. Study groups were matched for age, sex,
and BMI as shown in Table 1 and approved by the Mater Misericordiae
University Hospital Ethics committee.
PSP/reg enzyme-linked immunosorbent assay. The enzyme-linked immu-
nosorbent assay (ELISA) to quantify human PSP/reg was performed using
anti-sera from rabbits and guinea pigs immunized with recombinant human
PSP/reg protein as previously described (22,27). Serum was prepared by
centrifugation, and the IgG were puriﬁed by afﬁnity chromatography on
protein A columns. Subsequently, a sandwich ELISA was designed on 96-well
ELISA plates. Antibody of the ﬁrst species (guinea pig) was coated to the
bottom, blocked with BSA, and aliquots of serum were then incubated for 2 h.
After washing, antibodies of the other species (rabbit) were incubated.
Finally, a phosphatase-coupled anti-rabbit IgG was used. Patient serum
TABLE 1
Summary of the study groups used for ELISA measurement of
PSP/reg levels
Group
HNF1A-
MODY
HNF1A-
MODY
negative
Type 1
diabetes P value
n 1 671 0
Sex
(female:male) 10:6 4:3 6:4
Age (years) 35.8  20 27.9  11 31.8  4.9 NS
BMI (kg/m
2) 24.4  4 26.6  7.9 25.5  1.3 NS
A1C (%) 7.6  0.3* 5.4  0.3 7.8  0.3* P  0.05*
PSP (ng/ml) 18.8  2.7* 8.3  3.8 17.3  1.7* P  0.05*
Data are means  SE. Patients were age, sex, and BMI matched.
*P  0.05 vs. HNF1A-MODY–negative group.
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nant human PSP/reg.
Statistical analysis. Results were expressed as means  SE. Statistical
analysis was conducted using the SPSS version 15.0 software package for
Windows (SPSS). Differences between treatments were analyzed by Student t
test, as well as one-way ANOVA and a subsequent Tukey tests. Nonparametric
data were analyzed by Mann-Whitney U test. Differences were considered to
be signiﬁcant at P  0.05.
RESULTS
The inducible expression of DN-HNF1A leads to a
potent induction of PSP/reg mRNA and protein. In-
ducible, dominant-negative suppression of HNF1A func-
tion in INS-1 cells reduces the expression of HNF1A target
genes involved in glucose and lipid homeostasis (4) and
induces a caspase-dependent apoptosis (8). To investigate
the relationship between DN-HNF1A expression, activa-
tion of apoptosis, and induction of the regenerative PSP/
reg gene in particular, INS-1 cells stably transfected with
respective rtTA systems were induced to express either
DN-HNF1A or WT-HNF1A. We observed a time-dependent
induction of DN-HNF1A or WT-HNF1A mRNA in the
respective INS-1 cells (Fig. 1A). This correlated with a
signiﬁcant reduction in mRNA levels of pdk1, a known
HNF1A target gene (7), in response to DN-HNF1A expres-
sion but not WT-HNF1A (Fig. 1B). Examination of the
expression of the Reg family of genes in INS-1 cells
demonstrated that DN-HNF1A led to a potent induction of
the PSP/reg gene at 24 h (	15-fold) and 48 h (	30-fold).
Induction of WT-HNF1A for up to 48 h did not signiﬁcantly
regulate PSP/reg expression (Fig. 1C).
We next investigated PSP/reg protein levels after induc-
tion of DN-HNF1A. Cleavage of PSP/reg converts the
16-kDa proteins into a 14-kDa insoluble ﬁbrillar protein
(28). Western blot analysis demonstrated a signiﬁcant
upregulation of the PSP/reg protein (16 kDa) following
DN-HNF1A induction and a time-dependent increase in the
14 kDa form of PSP/reg (Fig. 1D).
High extracellular glucose levels potentiates PSP/
reg mRNA induction. We next determined whether the
induction of PSP/reg mRNA was glucose dependent.
Interestingly, we found that the DN-HNF1A induction of
PSP/reg mRNA expression was modulated by varying
extracellular glucose concentrations for 2 h following
DN-HNF1A induction. The increase in PSP/reg mRNA
expression was potentiated in a concentration-dependent
manner, with the highest induction evident at 18 mmol/l
(Fig. 2A).
Elevated PSP/reg levels in an HNF1A-MODY animal
model and in the serum of HNF1A-MODY patients. We
analyzed parafﬁn-embedded pancreatic sections from
5-month-old diabetic (Fig. 2B) mice expressing DN-HNF1A
in -cells and compared them with wild-type C57BL/
6JBomTac mice. Sections were costained for PSP/reg and
insulin. PSP/reg was expressed at low levels in wild-type
islets (36  1 PSP/reg-positive cells per islet; n  8 islets
from n  2 animals) and was found almost exclusively in
peripheral islet cells. In contrast, DN-HNF1A islets showed
signiﬁcantly elevated PSP/reg-positive islet cells (82  2
PSP/reg-positive cells per islet; n  8 islets from n  2
animals). Moreover, PSP/reg-positive cells were found to
be widespread throughout the transgenic islets and were
also detectable in insulin-negative islet cells. Strong ex-
pression was also observed in the surrounding acinar cells
(Fig. 2B). Interestingly, high magniﬁcation analysis sug-
gested that many islet cells with elevated PSP/reg immu-
noreactivity were positioned in the vicinity of cells
displaying apoptotic nuclear morphology (Fig. 2C).
We next sought to determine whether increased PSP/
Reg1a levels could also be detected in HNF1A-MODY
diabetic subjects. We analyzed serum PSP/Reg1a levels
in a group of 16 diabetic subjects with HNF1A-MODY
using ELISA. Results were compared with serum levels
in seven HNF1A-MODY–negative, nondiabetic family
members. PSP/Reg1a levels were signiﬁcantly elevated
in HNF1A-MODY subjects (Fig. 2D). Interestingly, we
also detected elevated PSP/Reg1a serum levels in the
serum of patients with type 1 diabetes (n  10 patients)
(Fig. 2D).
Induction of PSP/reg mRNA and protein by DN-
HNF1A function involves the activation of caspases.
Previously we demonstrated that DN-HNF1A–induced ap-
optosis of INS-1 cells required caspases and involved the
activation of the mitochondrial apoptosis pathway (8). To
assess whether the activation of executioner caspases
inﬂuenced DN-HNF1A–induced PSP/reg mRNA induction,
we ﬁrst determined the time course of DEVDase activation
(indicative of executioner caspase 3/7 activity) by moni-
toring the cleavage of a ﬂuorigenic caspase substrate. In
agreement with our earlier report (8), there was a signiﬁ-
cant caspase activity in the time frame of 24–48 h post
induction. Expression of WT-HNF1A or doxycycline treat-
ment of parental INS-1 cells did not activate caspases (Fig.
3A). Furthermore, DN-HNF1A induction mediated nuclear
morphological changes indicative of apoptosis with con-
densation and fragmented nuclei. Pretreatment with the
pancaspase inhibitor zVAD.fmk inhibited the occurrence
of this apoptotic morphology conﬁrming the caspase de-
pendence (Fig. 3B).
Given the similar kinetics of PSP/reg mRNA induction
and caspase activation, we explored the possibility that
caspase activation regulated PSP/reg expression. Indeed,
DN-HNF1A induction of PSP/reg expression was com-
pletely inhibited by pretreatment with zVAD.fmk (Fig. 3C
and D). Next we addressed whether DN-HNF1A induction
of PSP/reg mRNA could be sufﬁciently explained by its
ability to activate apoptosis. Indeed, induction of apopto-
sis in INS-1 cells with the topoisomerase inhibitor, etopo-
side, was sufﬁcient to increase PSP/reg mRNA levels in a
caspase-dependent manner (Fig. 3E).
Conditioned medium from DN-HNF1A–induced INS1
cells results in a prominent increase in PSP/reg
mRNA expression in naïve INS-1 cells. Executioner
caspases such as caspase 3 inactivate transcription and
translation processes (29), suggesting that apoptosing
cells were unlikely to be the source of increased PSP/
reg mRNA during DN-HNF1A–induced apoptosis. We
investigated whether this increased expression was due
to apoptosing cells sending a paracrine signal to neigh-
boring cells. After 48 h of DN-HNF1A induction in the
presence and absence of zVAD.fmk, the conditioned
medium was added directly to naïve INS-1 cells result-
ing in a 16-fold increase in PSP/reg mRNA levels in the
naïve INS1-cells (Fig. 4A). This induction was absent in
cultures incubated with the conditioned medium of
zVAD.fmk pretreated DN-HNF1A–induced cells (Fig.
4A) or heat-inactivated conditioned medium (Fig. 4B),
supporting the hypothesis that apoptotic cells secrete
heat-sensitive factor(s) that stimulate(s) PSP/reg gene
induction in neighboring cells.
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duction. Microparticles are small (100 nm) membrane
vesicles originating from blebbing membranes of apopto-
tic cells and can be identiﬁed by annexin V staining. These
microparticles may contain nuclear proteins as well as
nucleic acids (30,31). We examined if microparticles were
present in our conditioned medium and, if so, whether
these could modulate PSP/reg expression. After 48 h of
DN-HNF1A induction in the presence and absence of
zVAD.fmk, we enriched for microparticles in the superna-
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FIG. 1. The inducible expression of DN-HNF1A leads to a potent induction of PSP/reg mRNA and protein. A: The time course of the hnf1a gene
induction in DN-HNF1A and WT-HNF1A induced INS-1 cells, represented by absolute quantitative PCR (qPCR). Data are presented as cDNA copy
number per microliter. Data are represented as means  SE from n  3 cultures. The experiment was repeated three times with similar results.
*P < 0.05 indicates the difference from noninduced controls. B: Quantiﬁcation of the pyruvate dehydrogenase kinase (Pdk1) gene expression.
DN-HNF1A and WT-HNF1A INS-1 cells were induced with doxycycline from 0 to 48 h. Pdk1 mRNA expression was examined using real-time qPCR
relative to -actin. Data shown are the means  SEM of n  3 cultures. The experiment was repeated four times with similar results. *P < 0.05,
difference from noninduced controls. C: Quantiﬁcation of PSP/reg gene expression following DN-HNF1A and WT-HNF1A induction in INS-1 cells.
INS-1 cells were treated with 500 ng/ml doxycycline from 0 to 48 h. mRNA expression of PSP/reg was examined using real-time qPCR relative to
-actin. Expression levels were normalized to control cells and data represent means  SEM from n  3 cultures. *P < 0.05, difference from
noninduced controls. Experiments were repeated six times with similar results (D) whole cell lysates (25 g) were analyzed by Western blotting
on 15% SDS-PAGE. Membranes were probed with a polyclonal antibody recognizing PSP/reg. The 14-kDa fragment represents a PSP/reg cleavage
product. -Actin served as a loading control. Approximate molecular weights are provided on the right side of the ﬁgure. Similar results were
obtained in two separate experiments.
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to naïve INS-1 cells for a further 24 h. Naïve INS-1 cells
treated with the unﬁltered conditioned medium from
DN-HNF1A–induced cells had increased PSP/reg mRNA
levels that were abolished by ﬁltration of this conditioned
medium or by using unﬁltered medium from DN-HNF1A–
induced cultures in the presence of zVAD.fmk (Fig. 4C).
Importantly, ﬂow cytometry identiﬁed increased micropar-
ticle levels in the unﬁltered, compared with the ﬁltered,
conditioned medium from the same experiment, indicating
that microparticles were not generated by the isolation
procedure (Fig. 4D). Indeed, microparticles were at least
150-fold more abundant in unﬁltered compared with ﬁl-
tered conditioned medium with a signiﬁcantly reduced
level in zVAD.fmk pretreated unﬁltered medium (Fig. 4D).
These results suggest that caspases are required for mi-
croparticle formation, and their removal abolishes the
conditioned medium–induced PSP/reg mRNA expression
in naïve INS-1 cells.
Treatment of INS-1 cells with recombinant PSP/reg
protein reverses the DN-HNF1A–induced decrease in
cell proliferation and increases insulin mRNA levels.
Animal models of diabetes have demonstrated that recom-
binant PSP/reg (rPSP/reg) increases -cell ductal cell
proliferation (21,32). DN-HNF1A induction led to signiﬁ-
cant decreases in cell proliferation as detected by BrdU
incorporation, which was reversed by rPSP/reg treatment
(Fig. 5A). Decreased cell proliferation has been attributed
to DN-HNF1A–induced expression of the cell cycle inhib-
itor p27
Kip1 (8,9). Induction of DN-HNF1A led to increased
p27
Kip1 mRNA expression but did not affect p21
WAF1
expression (data not shown), with rPSP/reg cotreatment
reducing DN-HNF1A–induced p27
Kip1 expression (Fig.
5C). Furthermore, the rPSP/reg treatment rescued the
decrease in insulin gene expression induced by DN-
HNF1A expression (Fig. 5B). Taken together, our data
suggest that rPSP/reg treatment reverses the DN-HNF1A–
induced phenotype. Indeed, BrdU incorporation was also
signiﬁcantly elevated in naïve INS-1 cells treated with
conditioned cultured medium from DN-HNF1A–induced
cells compared with those induced in the presence of
zVAD.fmk (Fig. 5D).
DISCUSSION
The present study provides evidence that -cell apoptosis
may stimulate -cell regeneration. We demonstrate 1) that
dominant-negative suppression of HNF1A leads to apopto-
sis and a potent induction of PSP/reg; 2) this induction was
potentiated by increased extracellular glucose concentra-
tions; 3) the induction of PSP/reg was inhibited by the
broad-spectrum caspase inhibitor, zVAD.fmk, which also
inhibited DN-HNF1A–induced apoptosis; 4) conditioned
medium from DN-HNF1A–induced cells was sufﬁcient to
induce PSP/reg expression in naïve INS-1 cells, suggesting
that apoptosing INS-1 cells secrete factors that stimulate
PSP/reg induction in neighboring cells; 5) removal of
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FIG. 2. High extracellular glucose potentiates PSP/reg mRNA induc-
tion in DN-HNF1A expressing INS-1 cells. A: INS-1 cells were induced
to express DN-HNF1A for 24 h. Cultures were continued for2ha t
either 3, 6, 12, and 18 mmol/l glucose concentrations. After this period,
mRNA expression of PSP/reg was analyzed by real-time qPCR. Expres-
sion levels were normalized to noninduced control cells and data are
represented as means  SEM from n  3 cultures.* P< 0.05, difference
from non induced controls; #P < 0.05, difference from induced cultures
at 3 mmol/l glucose. Experiment was repeated three times with similar
results. B: PSP/reg immunoreactivity in islet cells in an in vivo mouse
model of DN-HNF1A–induced apoptosis. Parafﬁn-embedded pancreatic
sections on slides from 5-month-old wild-type C57BL/6JBomTac con-
trol mice and RIP-DN-HNF1A transgenic mice were double stained
using antibodies against PSP/reg and insulin. Primary antibodies were
recognized by secondary antibodies coupled to Rhodamine (red) for
PSP/reg and to FITC (green) for insulin, respectively. Cell nuclei were
stained with DAPI (blue). Bar  10 m. C: PSP/reg immunoreactivity in
islets cells in proximity to cells showing apoptotic nuclear morphology.
High magniﬁcation images of PSP/reg immunoreactivity and DAPI
staining in islets of DN-HNF1A mice. Arrows indicate cells exhib-
iting apoptotic nuclear morphology. Bar  10 m. D: PSP/reg protein is
detectable in the serum of HNF1A-MODY subjects and type 1 diabetic
subjects. Serum from HNF1A-MODY patients, their MODY-negative
family members, and type 1 diabetic patients were analyzed by a
speciﬁc ELISA detecting human PSP/reg. The square indicates the
normal range (R.G., historic data). Individual values, the average as
well as the SD are plotted. PSP/reg levels in HNF1A-MODY and type 1
diabetic subjects were signiﬁcantly different from MODY-negative,
control family members (*P < 0.05). (A high-quality digital represen-
tation of this ﬁgure is available in the online issue.)
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PSP/reg induction, suggesting that microparticles released
from blebbing membranes mediated this effect; 6) treat-
ment of INS-1 cells with rPSP/reg protein reversed the
DN-HNF1A–induced decrease in cell proliferation and
insulin mRNA; and 7) moreover, PSP/reg serum levels
were signiﬁcantly elevated in HNF1A-MODY patients and
type 1 diabetes compared with HNF1A-MODY–negative,
nondiabetic family members.
Regulation of -cell mass in HNF1A-MODY. Evidence
is growing that functional -cell mass is decreased in
animal models of MODY and in type 2 diabetes, with an
increased apoptosis rate largely contributing to this de-
crease (12,13,33). However, a decrease in -cell mass does
not necessarily implicate that new -cells are not gener-
ated during disease progression. Indeed, -cell mass is a
result of a homeostatic balance between the generation of
new -cells and the rate of their apoptosis (34). As
HNF1A-MODY and type 2 diabetes evolve over several
years or decades, the destruction or apoptosis rate of
-cells may eventually exceed the rate of -cell generation
during disease progression.
Although -cell regeneration may occur during disease
progression, it is not clear whether this happens through
self-replication of mature -cells, through neogenesis of
progenitor cells residing in the pancreas or recruited from
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FIG. 3. Activation of caspases during DN-HNF1A–induced apoptosis triggers PSP/reg induction. A: Time course of caspase-3–like protease activity
in whole-cell extracts. INS-1 cells were induced to overexpress WT-HNF1A or DN-HNF1A for 0, 16, 24, and 48 h. As a control, parental INS-1 cells
were treated with doxycycline for 0, 16, 24, and 48 h. Caspase protease activity was measured by cleavage of the ﬂuorigenic substrate
Ac-DEVD-AMC (10 mol/l). Activities are represented as increase in AMC ﬂuorescence (in AU) per 1 h per microgram of protein. Data represent
means  SE from n  6 cultures. Experiments were repeated two times with similar results. *P < 0.05, difference from noninduced controls. B:
Treatment with the broad spectrum caspase inhibitor zVAD.fmk (100 mol/l) inhibits apoptosis after induction of DN-HNF1A. Cultures were
simultaneously pretreated with doxycycline and zVAD.fmk or vehicle (DMSO; zVAD.fmk) for 48. Apoptotic cell morphology was assessed by DAPI
staining of nuclear chromatin. C: zVAD.fmk inhibits PSP/reg mRNA induction. The mRNA expression of PSP/reg was examined using real-time
qPCR. Expression levels were normalized to noninduced plus noninduced zVAD.fmk–treated control cells. Data are represented as means  SE
from n  3 cultures.*P < 0.05, difference from noninduced controls. #P < 0.05, difference compared with doxycycline alone–treated cultures. The
experiment was repeated three times with similar results. D: PSP/reg protein expression was detected by Western blotting. A duplicate
experiment showed similar results. Membrane was stripped and reprobed with anti–-actin as a loading control. E: PSP/reg gene induction in
parental INS-1 cells treated with etoposide is caspase dependent. INS-1 cells were simultaneously treated with etoposide (20 mol/l) or vehicle
(0.1% DMSO) for 24 h in the presence and absence of zVAD.fmk (100 mol/l). Following treatment, mRNA expression of PSP/reg was examined
using real-time qPCR. Expression levels were normalized to control cells. Data are represented as means  SE from n  3 separate cultures.* P<
0.05, difference from non induced controls. #P < 0.05, difference compared with etoposide alone–treated cultures. Data shown are the mean of
n  3 separate experiments.
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supply to our knowledge for the ﬁrst time evidence that
the interaction of -cell apoptosis and regeneration is
more complex and in fact that both processes may be
mechanistically linked. In our study, we observed that
dominant-negative suppression of HNF1A or apoptosis
induced by genotoxic stress (etoposide) led to caspase-
dependent apoptosis of INS-1 cells, associated with the
induction of the regenerative PSP/reg gene. Furthermore,
conditioned medium from apoptosing cells was sufﬁcient
to stimulate PSP/reg mRNA expression and BrdU incorpo-
ration in naïve INS-1 cells. These ﬁndings allow for the
conclusion that apoptosing -cells secrete factor(s) that
can stimulate regenerative gene induction and cellular
proliferation in neighboring cells. Finally, we demonstrate
that administration of rPSP/reg reversed the DN-HNF1A–
induced decrease in cell proliferation, supporting the
concept that -cell replication may be positively regulated
by -cell apoptosis. The ability of apoptotic cells to
provide signaling cues for their environment has been
demonstrated in other settings, such as inhibition of
inﬂammation. Interestingly, recent studies (35,36) have
demonstrated that caspase activation is required for tissue
regeneration during wound healing and planarian regener-
ation, suggesting that tissue regeneration in response to
caspase-dependent apoptosis may be an evolutionary con-
served process.
PSP/reg: biological effects and role in HNF1A-MODY.
The Reg family of proteins constitute a multigene family in
humans and rodents (19). PSP/reg increases -cell mass
and stimulates -cell proliferation under physiological
conditions and in 90% depancreatized and nicotinamide-
injected rats (19,37). Studies in mice lacking the gene
Reg1, the mouse homologue of PSP/reg, revealed that
Reg1 is involved in cell-cycle progression and normal islet
growth (37). Reg1 knockout mice have signiﬁcant reduc-
tions in islet cell mass and rate of DNA synthesis in
isolated islet cells (37,38). We identiﬁed that rPSP/
reg reversed the DN-HNF1A–induced upregulation of
p27
Kip1gene expression and the concomitant decrease in
insulin expression. Previous studies have shown that
PSP/reg induces extracellular signal–related kinase 1/2
signaling in MKN45 gastric cancer cells (39). However, the
signal transduction pathways activated by PSP/reg in
pancreatic islets warrant further investigation. Interest-
ingly, we observed that elevated extracellular glucose
concentrations rapidly potentiated PSP/reg gene expres-
sion. This may represent an important physiological feed-
back loop for the regulation of -cell mass.
PSP/reg is physiologically secreted from pancreatic aci-
nar cells (20). In the adult rat, PSP/reg has been shown to
be present only in small amounts in -cells (20,40). We
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FIG. 4. Conditioned medium from DN-HNF1A–induced INS-1 cells
results in a prominent increase in PSP/reg mRNA expression in naïve
INS1 Cells. A: INS-1 cells were induced with 500 ng/ml of doxycycline in
the presence and absence of zVAD.fmk (100 mol/l) at 0.05% serum in
6 mmol/l glucose for 48 h. The conditioned culture medium was added
to the noninduced, naive cells for a further 24 h. After treatment,
mRNA expression of PSP/reg was analyzed by real-time qPCR. Expres-
sion levels were normalized to noninduced controls. Data are repre-
sented as means  SE from n  3 cultures.* P< 0.05, difference from
noninduced controls; #P < 0.05, difference from doxycycline alone–
treated cultures. Experiments were repeated six times with similar
results. B: Duplicate experiments of INS-1 cells were induced for 48 h.
Conditioned culture medium was heat inactivated at 95°C for 15 min
and added to the naive cells for a further 24 h. PSP/reg gene expression
was analyzed by real-time qPCR. Data are represented as means  SE
from n  3 cultures.* P< 0.05, difference from noninduced controls.
Experiments were repeated four times with similar results. C: The
conditioned medium from cells treated as described in A above was
centrifuged and ﬁltered through 0.20 m ﬁlters and added to naïve
INS-1 cells for 24 h. Unﬁltered conditioned medium served as a control.
PSP/reg gene expression was analyzed by real-time qPCR. Data are
represented as means  SE from n  3 cultures.* P< 0.05, difference
from noninduced controls. Experiments were repeated three times
with similar results. D: INS-1 cells were induced with doxycycline in
the presence and absence of zVAD.fmk. The conditioned culture me-
dium was added to naive cells for a further 24 h. Supernatants were
collected and detached cells were precipitated at (300g), followed by
additional 800g centrifugation. Microparticles were quantiﬁed as de-
scribed in RESEARCH DESIGN AND METHODS.
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tive islet cells in 5-month-old transgenic HNF1A-MODY
mice, conﬁrming previous ﬁndings that PSP/reg is ex-
pressed in islets during injury and regeneration processes
(17,19). Moreover, PSP/reg was also found in insulin-
negative islet cells (Fig. 2B). In this context, a recent study
has suggested -cells to be the major source of -cell
regeneration/conversion in mice in vivo (41). We also
detected increased PSP/reg levels in the serum of HNF1A-
MODY patients. We can only speculate whether the source
of PSP/reg in the serum of HNF1A-MODY patients was the
endocrine or exocrine pancreas (i.e., islet or acinar cells).
We can likewise not exclude that these levels came from
other organs potentially affected in HNF1A-MODY, such as
the liver, where PSP/reg is also expressed (42). However,
we also detected elevated levels of PSP/reg in subjects
with type 1 diabetes, arguing for a role for pancreatic
injury and -cell apoptosis as a source for elevated PSP/
reg serum levels.
Microparticles as signal transducers or enablers. In
our study, we detected that apoptotic INS-1 cells released
annexin V–positive microparticles into the medium in a
caspase-dependent manner. Microparticles are being in-
creasingly described as efﬁcient vehicles for the release of
signaling molecules. Microparticles enable communica-
tion between different cell types (43) and also deliver
proteins to cells that do not normally express them (44).
Microparticles deriving from apoptotic cells have been
shown to carry nuclear proteins as well as nucleic acids
(31,45). Filtration experiments suggested that the absence
of microparticles abolished the effect of the conditioned
medium to induce PSP/reg mRNA in naïve INS-1 cells. This
suggested that cytokines, peptide hormones, or other
soluble messengers present in the conditioned medium did
not mediate this effect. Interestingly, heat inactivation of
the conditioned medium was sufﬁcient to inhibit PSP/reg
mRNA expression in naïve INS-1 cells. It is therefore
tempting to speculate that microparticles may contain
signaling molecules or nuclear proteins which, upon up-
take by neighboring cells, enhanced PSP/reg gene expres-
sion in these cells.
In conclusion, our study demonstrates that the exe-
cution of caspase-dependent apoptosis in INS-1 cells
stimulates the induction of regenerative genes in neigh-
boring cells, suggesting a role for MPs and PSP/reg in
this process. These ﬁndings provide new mechanistic
insights into a fundamental aspect of -cell mass
regulation.
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